We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
Cap. Flow
+$208M
Cap. Flow %
11.48%
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$9.12M
2
V icon
Visa
V
+$8.75M
3
MSI icon
Motorola Solutions
MSI
+$7.37M
4
EW icon
Edwards Lifesciences
EW
+$7.3M
5
CTXS
Citrix Systems Inc
CTXS
+$4.48M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.1M
2
BHC icon
Bausch Health
BHC
+$5.94M
3
DE icon
Deere & Co
DE
+$5.72M
4
STZ icon
Constellation Brands
STZ
+$4.59M
5
QCOM icon
Qualcomm
QCOM
+$4.55M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 13.48%
3 Consumer Discretionary 12.62%
4 Technology 11.4%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXFT
2001
DELISTED
Luxoft Holding, Inc.
LXFT
-22,038
Closed -$1.21M
HIFR
2002
DELISTED
InfraREIT, Inc.
HIFR
-22,676
Closed -$387K
HZNP
2003
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-16,803
Closed -$278K
SGYP
2004
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-22,800
Closed -$63K
SPA
2005
DELISTED
Sparton
SPA
-11,400
Closed -$205K
SN
2006
DELISTED
Sanchez Energy Corporation
SN
-104,946
Closed -$576K
GNBC
2007
DELISTED
Green Bancorp, Inc
GNBC
-15,322
Closed -$116K
KERX
2008
DELISTED
Keryx Biopharmaceuticals Inc
KERX
-47,664
Closed -$223K
FCE.A
2009
DELISTED
Forest City Realty Trust, Inc.
FCE.A
-13,273
Closed -$280K
MITL
2010
DELISTED
Mitel Networks Corporation
MITL
-18,405
Closed -$151K
LHO
2011
DELISTED
LaSalle Hotel Properties
LHO
-18,229
Closed -$461K
PF
2012
DELISTED
Pinnacle Foods, Inc.
PF
-14,204
Closed -$635K
NDRO
2013
DELISTED
Enduro Royalty Trust
NDRO
-77,311
Closed -$211K
PAY
2014
DELISTED
Verifone Systems Inc
PAY
-7,716
Closed -$218K
EVEP
2015
DELISTED
EV Energy Partners, L.P.
EVEP
-171,400
Closed -$333K
BBG
2016
DELISTED
Bill Barrett Corp
BBG
-78,988
Closed -$491K
AGU
2017
DELISTED
Agrium
AGU
-4,685
Closed -$414K
GIMO
2018
DELISTED
Gigamon Inc.
GIMO
-26,524
Closed -$823K
VALE.P
2019
DELISTED
Vale S A
VALE.P
-13,698
Closed -$43K
BRCD
2020
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
-87,313
Closed -$924K
WNRL
2021
DELISTED
Western Refining Logistics, LP
WNRL
-12,900
Closed -$301K
TERP
2022
DELISTED
TerraForm Power, Inc
TERP
-65,771
Closed -$569K
ALR
2023
DELISTED
Alere Inc
ALR
-6,327
Closed -$320K
GUID
2024
DELISTED
Guidance Software, Inc.
GUID
-19,409
Closed -$83K
MACK
2025
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-1,723
Closed -$113K

Similar funds

GSA Capital Partners's Q2 2016 Portfolio in Review

As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.

GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.

  • GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
  • GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
  • GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
  • GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
  • GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
  • GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
  • GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.

Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.